传统的批次生产，如同分批次烘焙蛋糕，每个批次独立进行，工序之间存在中断和等待。这一模式在生产相对简单的单克隆中国生物制药行业正站在一个关键的十字路口。从资本驱动的高速扩张，转向一个由成本、效率和全球化竞争定义的新阶段。 产业焦点已从“能否做出新药”转向“如何高效、稳定且具备全球竞争力地制造新药”，生产工艺，这个曾经的幕后环节，正被推向战略前台。 近期一场工艺峰会将行业目光聚焦于此。主办方赛多利斯，...
Source Link传统的批次生产，如同分批次烘焙蛋糕，每个批次独立进行，工序之间存在中断和等待。这一模式在生产相对简单的单克隆中国生物制药行业正站在一个关键的十字路口。从资本驱动的高速扩张，转向一个由成本、效率和全球化竞争定义的新阶段。 产业焦点已从“能否做出新药”转向“如何高效、稳定且具备全球竞争力地制造新药”，生产工艺，这个曾经的幕后环节，正被推向战略前台。 近期一场工艺峰会将行业目光聚焦于此。主办方赛多利斯，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.